US Exchange Filings

DataMEDS AI CEO Gerald Commissiong Purchases 5,000 Shares in Open Market

DataMEDS AI co-CEO Gerald Commissiong bought 5,000 shares on the open market at $1.09 each, a $5,450 personal investment. The purchase may draw investor attention, but it provides no new capital to the company.

DataMEDS AI Co-Chief Executive Officer Gerald Commissiong bought 5,000 shares of the company’s common stock on Nov. 20, an open-market purchase rather than a financing transaction by the company.

  • Commissiong paid $1.09 per share, for a total purchase price of $5,450.
  • The shares trade on the Nasdaq Capital Market under the ticker MEDS.
  • The purchase does not provide capital to DataMEDS; it was made by Commissiong in the market. The announcement did not state his total shareholdings after the purchase.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.